drugset / Trial / NCT03056664
The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
Here investigators will carry out this phase II clinical trial to explore a effective therapeutic regimen of MSC in the Crohn's perianal fistula.
Timeline
- Start
- 2017-01
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MSC | Cell therapy | 3e+06 cells/kg | Other |
| Subject | MSC | Cell therapy | 6e+06 cells/kg | Other |